Valuation Stryker Corporation Mexican S.E.
Stocks
SYK *
US8636671013
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Mexican S.E.
15/09/2026
|
5-day change | 1st Jan Change | ||
| 4,828.00 MXN | +1.22% |
|
+1.22% | -24.56% |
| 09-18 | Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating | MT |
| 09-17 | Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says | MT |
Company Valuation: Stryker Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 100,882 | 92,522 | 113,776 | 137,257 | 134,410 | 105,529 | - | - |
| Change | - | -8.29% | 22.97% | 20.64% | -2.07% | -21.49% | - | - |
| Enterprise Value (EV) 1 | 110,335 | 102,451 | 121,655 | 144,952 | 146,258 | 114,654 | 111,421 | 108,054 |
| Change | - | -7.14% | 18.74% | 19.15% | 0.9% | -21.61% | -2.82% | -3.02% |
| P/E | 51.3x | 39.6x | 36.3x | 46.4x | 41.8x | 21.4x | 18.6x | 16.5x |
| PBR | 6.79x | 5.56x | 6.11x | 6.65x | 5.99x | 4.01x | 3.46x | 2.98x |
| PEG | - | 2.1x | 1.1x | -7.81x | 5.07x | 0.4x | 1.3x | 1.3x |
| Capitalization / Revenue | 5.9x | 5.02x | 5.55x | 6.07x | 5.35x | 3.87x | 3.56x | 3.31x |
| EV / Revenue | 6.45x | 5.55x | 5.93x | 6.42x | 5.82x | 4.21x | 3.76x | 3.38x |
| EV / EBITDA | 23.2x | 21.5x | 22.7x | 23.6x | 20.7x | 14.7x | 13x | 11.4x |
| EV / EBIT | 25.2x | 23.4x | 24.6x | 25.4x | 22.2x | 15.8x | 13.8x | 12.2x |
| EV / FCF | 40.3x | 50.3x | 39.2x | 41.6x | 34.1x | 28.5x | 22.4x | 19x |
| FCF Yield | 2.48% | 1.99% | 2.55% | 2.41% | 2.93% | 3.5% | 4.47% | 5.28% |
| Dividend per Share 2 | 2.585 | 2.835 | 3.05 | 3.24 | 3.4 | 3.598 | 3.828 | 4.112 |
| Rate of return | 0.97% | 1.16% | 1.02% | 0.9% | 0.97% | 1.31% | 1.39% | 1.49% |
| EPS 2 | 5.21 | 6.17 | 8.25 | 7.76 | 8.4 | 12.86 | 14.76 | 16.64 |
| Distribution rate | 49.6% | 45.9% | 37% | 41.8% | 40.5% | 28% | 25.9% | 24.7% |
| Net sales 1 | 17,108 | 18,449 | 20,498 | 22,595 | 25,116 | 27,252 | 29,629 | 31,929 |
| EBITDA 1 | 4,753 | 4,755 | 5,348 | 6,142 | 7,064 | 7,804 | 8,577 | 9,446 |
| EBIT 1 | 4,382 | 4,384 | 4,955 | 5,715 | 6,603 | 7,278 | 8,052 | 8,886 |
| Net income 1 | 1,994 | 2,358 | 3,165 | 2,993 | 3,246 | 4,942 | 5,746 | 6,397 |
| Net Debt 1 | 9,453 | 9,929 | 7,879 | 7,695 | 11,848 | 9,125 | 5,893 | 2,525 |
| Reference price 2 | 267.42 | 244.49 | 299.46 | 360.05 | 351.47 | 275.12 | 275.12 | 275.12 |
| Nbr of stocks (in thousands) | 377,240 | 378,430 | 379,938 | 381,216 | 382,424 | 383,573 | - | - |
| Announcement Date | 1/27/22 A | 1/31/23 A | 1/30/24 A | 1/28/25 A | 1/29/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.39x | 4.21x | 14.69x | 1.31% | 106B | |
| 17.42x | 2.23x | 8.68x | 2.94% | 11.56B | |
| -202.51x | 13.73x | 1629.64x | -.--% | 9.66B | |
| 21.33x | 9.83x | 17.02x | 1.93% | 4.02B | |
| 23.26x | - | - | - | 2.34B | |
| -1781.44x | 2.2x | 10.31x | -.--% | 2.22B | |
| 16.29x | 4.25x | 8.3x | 3.76% | 1.53B | |
| Average | -269.18x | 6.07x | 281.44x | 1.66% | 19.55B | |
| Weighted average by Cap. | -24.01x | 4.86x | 130.04x | 1.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SYK Stock
- SYK * Stock
- Valuation Stryker Corporation
Select your edition
All financial news and data tailored to specific country editions
